Udonitrectag methyl ester

N/A

Report date: 2025/03/17 11:12:46
NME

Base Information

Drug NameUdonitrectag methyl ester
Drug Alias NameMT-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis inhibitorsAutophagy inhibitorsNerve growth factor receptor Trk-A agonists +[4] 
TargetsNerve growth factor receptor Trk-ANeurotrophic tyrosine kinase receptor type 2
Therapy Area/IndicationsHeart ArrestAmyotrophic Lateral SclerosisParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMimetech SRL
China Registration ClassN/A

Develop Information

Active CompaniesMimetech SRL
Inactive CompaniesN/A
Active IndicationsHeart ArrestAmyotrophic Lateral SclerosisParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A